BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7679076)

  • 1. 5 beta-Methyl-14 beta-(p-nitrocinnamoylamino)-7,8-dihydromorphinone: a long-lasting mu-opioid receptor antagonist devoid of agonist properties.
    Jiang Q; Sebastian A; Archer S; Bidlack JM
    Eur J Pharmacol; 1993 Jan; 230(1):129-30. PubMed ID: 7679076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5 beta-Methyl-14 beta-(p-nitrocinnamoylamino)-7,8-dihydromorphinone and its corresponding N-cyclopropylmethyl analog, N-cyclopropylmethylnor-5 beta-methyl-14 beta-(p-nitrocinnamoylamino)- 7,8-dihydromorphinone: mu-selective irreversible opioid antagonists.
    Jiang Q; Sebastian A; Archer S; Bidlack JM
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1107-13. PubMed ID: 7511163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 14 beta-Chlorocinnamoylamino derivatives of metopon: long-term mu-opioid receptor antagonists.
    McLaughlin JP; Sebastian A; Archer S; Bidlack JM
    Eur J Pharmacol; 1997 Feb; 320(2-3):121-9. PubMed ID: 9059844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-cyclobutylmethyl analog of normorphinone, N-CBM-TAMO: a short-term opioid agonist and long-term Mu-selective irreversible opioid antagonist.
    Xu JY; Seyed-Mozaffari A; Archer S; Bidlack JM
    J Pharmacol Exp Ther; 1996 Nov; 279(2):539-47. PubMed ID: 8930155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitrocinnamoyl and chlorocinnamoyl derivatives of dihydrocodeinone: in vivo and in vitro characterization of mu-selective agonist and antagonist activity.
    McLaughlin JP; Hill KP; Jiang Q; Sebastian A; Archer S; Bidlack JM
    J Pharmacol Exp Ther; 1999 Apr; 289(1):304-11. PubMed ID: 10087018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing morphine antinociceptive tolerance by irreversible mu opioid antagonists before the onset of their antagonism.
    Jiang Q; Seyed-Mozaffari A; Sebastian A; Archer S; Bidlack JM
    J Pharmacol Exp Ther; 1995 May; 273(2):680-8. PubMed ID: 7752070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociceptive properties of two alkylating derivatives of morphinone: 14 beta-(thioglycolamido)-7,8-dihydromorphinone (TAMO) and 14 beta-(bromoacetamido)-7,8-dihydromorphinone (H2BAMO).
    Jiang Q; Seyed-Mozaffari A; Archer S; Bidlack JM
    J Pharmacol Exp Ther; 1992 Aug; 262(2):526-31. PubMed ID: 1380079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinociceptive evaluation of 14 beta-(bromoacetamido)-7,8-dihydro- N(cyclopropylmethyl)-normorphinone in mice.
    Jiang Q; Seyed-Mozaffari A; Archer S; Bidlack JM
    Eur J Pharmacol; 1993 Aug; 240(2-3):201-6. PubMed ID: 7694857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metopon and two unique derivatives: affinity and selectivity for the multiple opioid receptors.
    McLaughlin JP; Nowak D; Sebastian A; Schultz AG; Archer S; Bidlack JM
    Eur J Pharmacol; 1995 Dec; 294(1):201-6. PubMed ID: 8788432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological study of 14 beta-(thioglycolamido)-7,8-dihydro-N(cyclopropylmethyl)-normor phinone (N-CPM-TAMO).
    Jiang Q; Seyed-Mozaffari A; Archer S; Bidlack JM
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1021-7. PubMed ID: 7680715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a novel bivalent morphinan possessing kappa agonist and micro agonist/antagonist properties.
    Mathews JL; Peng X; Xiong W; Zhang A; Negus SS; Neumeyer JL; Bidlack JM
    J Pharmacol Exp Ther; 2005 Nov; 315(2):821-7. PubMed ID: 16076937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the structurally novel opioid 14 alpha, 14' beta-[dithiobis [(2-oxo-2,1-ethanediyl)imino]]bis(7,8-dihydromorphinone) on schedule-controlled behavior and thermal nociception in rhesus monkeys.
    Gatch MB; Negus SS; Mello NK; Archer S; Bidlack JM
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1282-9. PubMed ID: 8819513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
    Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of GABA receptor antagonists injected spinally on antinociception induced by opioids administered supraspinally in mice.
    Suh HW; Kim YH; Choi YS; Choi SR; Song DK
    Eur J Pharmacol; 1996 Jun; 307(2):141-7. PubMed ID: 8832215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nociceptin/orphanin FQ blocks the antinociception induced by mu, kappa and delta opioid agonists on the cold water tail-flick test.
    Chen X; Geller EB; Adler MW
    Eur J Pharmacol; 2007 Feb; 557(1):32-6. PubMed ID: 17173891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of delta 9-tetrahydrocannabinol-induced analgesia by morphine in mice: involvement of mu- and kappa-opioid receptors.
    Reche I; Fuentes JA; Ruiz-Gayo M
    Eur J Pharmacol; 1996 Dec; 318(1):11-6. PubMed ID: 9007506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine.
    Broadbear JH; Sumpter TL; Burke TF; Husbands SM; Lewis JW; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2000 Sep; 294(3):933-40. PubMed ID: 10945843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
    Tseng LF; Collins KA
    J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective antagonism by naloxonazine of antinociception by Tyr-D-Arg-Phe-beta-Ala, a novel dermorphin analogue with high affinity at mu-opioid receptors.
    Sakurada S; Takeda S; Sato T; Hayashi T; Yuki M; Kutsuwa M; Tan-No K; Sakurada C; Kisara K; Sakurada T
    Eur J Pharmacol; 2000 Apr; 395(2):107-12. PubMed ID: 10794815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.